Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2018-03-10 2018-03-09
Drug Identification Number 02230454 02230454
Brand name BROMOCRIPTINE BROMOCRIPTINE
Common or Proper name BRMOCRIPTINE BRMOCRIPTINE
Company Name AA PHARMA INC AA PHARMA INC
Ingredients BROMOCRIPTINE BROMOCRIPTINE
Strength(s) 5MG 5MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 Bottle 100 Bottle
ATC code N04BC N04BC
ATC description DOPAMINERGIC AGENTS DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-03-02 2018-03-02
Estimated end date Unknown Unknown
Actual end date 2018-03-09 2018-03-09
Shortage status Resolved Actual shortage
Company comments
Health Canada comments